Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Generics
Pharma
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
AZ and Daiichi reported a positive phase 3 trial in TNBC. InnoCare and Zenas signed a potential $2 billion deal. Lupin will build a new U.S. plant.
Angus Liuu
Oct 10, 2025 10:55am
Trump carves out generics from US-Japan trade deal
Sep 8, 2025 11:50am
Teva launches first generic version of Novo's GLP-1 Saxenda
Aug 28, 2025 3:45pm
CSL's Venofer finally faces generic competition
Aug 13, 2025 2:06pm
Teva execs aren't sweating newly unveiled pharmaceutical tariffs
Jul 30, 2025 11:11am
Amphastar lays out plan to quadruple production capacity at HQ
Jul 16, 2025 7:53am
